PlainRecalls
FDA Drug Moderate Class II Terminated

Clonazepam Tablets, USP 2 mg 100 tablets Manufactured by: Actavis Elizabeth LLC 200 Elmora Avenue, Elizabeth, NJ 0737 USA NDC 0228-3005-11 packaged in White/Round HDPE 75 CC with white/round plastic 33 mm CRC closure shipped in corrugated 75 cc carton (24 bottles/carton)

Reported: March 5, 2014 Initiated: November 6, 2013 #D-1087-2014

Product Description

Clonazepam Tablets, USP 2 mg 100 tablets Manufactured by: Actavis Elizabeth LLC 200 Elmora Avenue, Elizabeth, NJ 0737 USA NDC 0228-3005-11 packaged in White/Round HDPE 75 CC with white/round plastic 33 mm CRC closure shipped in corrugated 75 cc carton (24 bottles/carton)

Reason for Recall

Subpotent Drug: During routine stability testing one tablet was found with tablet weight below specification.

Details

Recalling Firm
Actavis Elizabeth LLC
Units Affected
13,608 bottles
Distribution
Nationwide
Location
Elizabeth, NJ

Frequently Asked Questions

What product was recalled?
Clonazepam Tablets, USP 2 mg 100 tablets Manufactured by: Actavis Elizabeth LLC 200 Elmora Avenue, Elizabeth, NJ 0737 USA NDC 0228-3005-11 packaged in White/Round HDPE 75 CC with white/round plastic 33 mm CRC closure shipped in corrugated 75 cc carton (24 bottles/carton). Recalled by Actavis Elizabeth LLC. Units affected: 13,608 bottles.
Why was this product recalled?
Subpotent Drug: During routine stability testing one tablet was found with tablet weight below specification.
Which agency issued this recall?
This recall was issued by the FDA Drug on March 5, 2014. Severity: Moderate. Recall number: D-1087-2014.